Company & Sponsor Intelligence

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials17
Recruiting0
Completed13
Countries4

Therapeutic footprint

bipolar_disorderdepressionepilepsypain_neuropathyptsd

Indexed studies

NCT00537238Pregabalin Versus Levetiracetam In Partial Seizures
epilepsy · Belgium
PHASE3
NCT01607593A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
ptsd · Japan
COMPLETED
NCT00596466Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
epilepsy · United States
PHASE3
NCT01474772Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
pain_neuropathy · United States
PHASE3
NCT00684424Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
epilepsy ·
COMPLETED
NCT00620555A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
epilepsy · Japan
PHASE3
NCT01485887Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
depression · Japan
PHASE3
NCT01747915A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
epilepsy · United States
PHASE3
NCT01049217Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
pain_neuropathy · United States
PHASE3
NCT00280566Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
bipolar_disorder · United States
PHASE3
NCT01057693Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
pain_neuropathy · United States
PHASE3
NCT01271933Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
pain_neuropathy · United States
PHASE3

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →